-
ICD-10-CM Codes
›
-
C00-D49
›
-
C7A-C7A
›
-
C7A-
›
-
2023 ICD-10-CM Diagnosis Code C7A.098
2023 ICD-10-CM Diagnosis Code C7A.098
Malignant carcinoid tumors of other sites
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- C7A.098 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM C7A.098 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C7A.098 - other international versions of ICD-10 C7A.098 may differ.
The following code(s) above
C7A.098 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
C7A.098:
Approximate Synonyms
- Cancer neuroendocrine tumor, pancreas
- Malignant carcinoid tumor of nasal cavity
- Malignant carcinoid tumor, nasal cavity
- Primary malignant neuroendocrine tumor of pancreas
ICD-10-CM C7A.098 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
Convert C7A.098 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to C7A.098:
ICD-10-CM Codes Adjacent To C7A.098
C7A.026 Malignant carcinoid tumor of the rectum
C7A.029 Malignant carcinoid tumor of the large intestine, unspecified portion
C7A.09 Malignant carcinoid tumors of other sites
C7A.090 Malignant carcinoid tumor of the bronchus and lung
C7A.091 Malignant carcinoid tumor of the thymus
C7A.092 Malignant carcinoid tumor of the stomach
C7A.093 Malignant carcinoid tumor of the kidney
C7A.094 Malignant carcinoid tumor of the foregut, unspecified
C7A.095 Malignant carcinoid tumor of the midgut, unspecified
C7A.096 Malignant carcinoid tumor of the hindgut, unspecified
C7A.098
Malignant carcinoid tumors of other sites
C7A.1 Malignant poorly differentiated neuroendocrine tumors
C7A.8 Other malignant neuroendocrine tumors
C7B Secondary neuroendocrine tumors
C7B.0 Secondary carcinoid tumors
C7B.01 …… of distant lymph nodes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.